February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

CDC Reports Increase in Child and Severe Adult Obesity

From 2013 to 2023, severe obesity increased annually by 0.23 percentage points, according to new NHANES data.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

FDA Clears Rapid GI Test Panel for Gastroenteritis Detection

Clearance was granted to bioMérieux's BIOFIRE FILMARRAY GI Panel Mid, a 1-hour molecular test that can detect 11 common gastroenteritis-causing pathogens from a single stool sample.

Conexiant

February 10, 2025

Children With Autism and Medical Complexity Account for Disproportionate Health Care Costs

Children with both autism spectrum disorder and medical complexity have higher health care expenditures than those with autism spectrum disorder or medical complexity alone.

Conexiant

February 10, 2025

Dupilumab for Pediatric EoE: Phase III Histologic Remission Findings

Researchers found that dupilumab improved histologic remission in pediatric patients with eosinophilic esophagitis.

Conexiant

February 06, 2025

Patient Can't Burp? Botox May Help

In-office botulinum toxin injections achieved a 90% success rate in treating retrograde cricopharyngeus dysfunction.

Conexiant